Vesa Manninen
176 works · 14,060 citations · h-index 42
Top works
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
- Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study
- Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
- Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
- Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study
- Infections, Inflammation, and the Risk of Coronary Heart Disease
- Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy
- The Helsinki Heart Study: Basic design and randomization procedure
- Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study
- Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial
- Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values
- ALTERED ABSORPTION OF DIGOXIN IN PATIENTS GIVEN PROPANTHELINE AND METOCLOPRAMIDE
- Minimal doses of digoxin: A new marker for compliance to medication
- Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up study
- Anti-Cardiolipin Antibodies and Risk of Myocardial Infarction in a Prospective Cohort of Middle-Aged Men
- SERUM-DIGOXIN CONCENTRATIONS DURING TREATMENT WITH DIFFERENT PREPARATIONS
- Helsinki Heart Study
- Efficacy of Gemfibrozil in Dyslipidaemic Subjects with Suspected Heart Disease. An Ancillary Study in the Helsinki Heart Study Frame Population
- Clinical results with gemfibrozil and background to the Helsinki Heart Study